In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education, and research.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Artificial intelligence in medicine: How it works, how it fails,” authors Rick Rejeleene, PhD, and Neil B. Mehta, MBBS, MS, join moderator Adam Brown, MD, Cleveland Clinic. The trio discusses AI’s transformation of healthcare, with large language models emerging as important tools for clinical practice, education, and research.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Complement inhibition: A whole new world,” lead author Dr. Nicholas Salupo, and senior author, Dr. Ali Mehdi, Cleveland Clinic, join moderator Dr. Narbeh Melikian, Cleveland Clinic London. The trio discusses the complement system, a central component of the innate immune system, and bridge to the adaptive immune system.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

In this two-part podcast featuring the Cleveland Clinic Journal of Medicine article, “Update on antiobesity pharmacotherapy in adults: Current and emerging options,” Dr. Farah Ziyadeh, and Dr. Yael Mauer, Cleveland Clinic, join moderator Dr. Craig Nielsen, Cleveland Clinic. The trio discusses available antiobesity medications, including the incretin mimetics, and emerging antiobesity medications currently under investigation.

Listen as Dr. Astefanos Al-Dalakta and Dr. Ashish Sarraju, Cleveland Clinic, join moderator Dr. George Thomas, Cleveland Clinic, to discuss what clinicians need to know about lipoprotein(a) in clinical practice. Topics discussed include summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).

This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

This two-part podcast moderated by Dr. Adam Brown, Cleveland Clinic, features a discussion with Philip Zuccaro, BS, and Vasilis Vasiliou, PhD, both of the Yale School of Public Health, on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Does my patient need testing for PFAS ‘forever chemicals’?”

This podcast moderated by Dr. Craig Nielsen features a discussion with Dr. Maximilian C. Volk, and Dr. Luke J. Laffin, Cleveland Clinic on the Cleveland Clinic Journal of Medicine 1-minute consult article, “Should I consider Cy for my patient with high blood pressure?”